Charmey A, Bornhauser BC. Tripping the switch: p38 inhibition unlocks venetoclax and inotuzumab ozogamicin synergy. haematol [Internet]. 2020Sep.10 [cited 2026Aug.25];. Available from: https://haematologica.org/article/view/14355